[ORGANIZATION]
American Society of Clinical Oncology
Featured in 6 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
216 clusters · 804 sources · last updated
Latest: GLP-1 drugs face scrutiny over healthcare costs and bone health
Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. While research suggests secondary benefits—including a 21% lower risk of fragili
Corcept Therapeutics stock volatility and insider trading
2 clusters · 4 sources · last updated
Latest: Corporate insiders execute various stock transactions
Corcept Therapeutics experienced a significant stock surge of approximately 228%, reaching a price of $117.17 by August 18, 2026. This growth was linked to an investment by Donald Trump, FDA support for a New Drug Applic
Daraxonrasib trial shows doubled survival, EMA review on-go
31 clusters · 137 sources · last updated
Latest: Daraxonrasib doubles survival rates in pancreatic cancer trials
The rolling EMA review of the oral KRAS-targeting inhibitor daraxonrasib, launched on 7 July 2026, continues as new clinical data emerge. A multinational phase-III trial reported on 25 July that daraxonrasib doubled medi
Pfizer lorlatinib long‑term lung cancer results
2 clusters · 4 sources · last updated
Latest: Pfizer's lorlatinib cuts intracranial progression risk 94% in ALK‑positive lung cancer
Pfizer presented a seven‑year update of the phase III CROWN trial at the 2026 American Society of Clinical Oncology (ASCO) meeting. The trial compared lorlatinib with crizotinib as first‑line therapy for patients with ad
Also covered in
-
ASTRO updates radiation therapy guidelines for pancreatic cancer
[HEALTH] · 2 sources ·